ArticleNature communications2026
Simultaneous dual-Raman-shift scanning-free stimulated Raman scattering microscopy for label-free biomolecular imaging.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Simultaneous dual-Raman-shift scanning-free stimulated Raman scattering microscopy for label-free biomolecular imaging.Nature communications · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Conventional stimulated Raman scattering (SRS) microscopy requires time-consuming Raman-shift scanning to achieve chemical specificity, limiting its application in real-time biological studies. We present simultaneous dual-Raman-shift scanning-free SRS (SDRSRS) microscopy, which captures different distinct molecular vibrational signatures simultaneously without spectral scanning, achieving more than 10-fold faster imaging while maintaining high chemical specificity. The system uses birefringent crystals to create controlled optical path differences and orthogonal polarizations, enabling dual-phase modulation with custom dual-channel detection. The collinear balanced detection mode provides 11 dB signal-to-noise ratio improvement, and the system is compatible with other real-time imaging modalities. SDRSRS enables simultaneous CH₃ and CH₂ mapping to reveal lipid droplet dynamics in living cells, quantitatively distinguishes immunotherapy responses in liver cancer models, and provides rapid label-free classification of human colorectal cancer. This technique enables rapid and simultaneous dual vibrational contrast, providing chemically specific imaging for live metabolic monitoring, clinical pathology, and drug-response studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.